SAN MARINO, CA and MANILA, Philippines – July 5 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies today announced the opening of a Vaccine-assisted Phase I/II clinical trial for metastatic breast cancer that is refractory to conventional chemotherapy. The innovative protocol introduces Reximmune-C(TM), the second in a series of targeted biologic therapies designed to seek out, accumulate in, and destroy metastatic tumor nodules, while sparing normal cells and tissues.
Medical Devices News - Page 5
Page 5 of Medical Devices News issued by the Send2Press® Newswire service.
| From: Reaction Biology Corporation
MALVERN, PA – Mar. 13 (SEND2PRESS NEWSWIRE) — Reaction Biology Corporation (‘RBC’) today announced that it has been awarded an R01 grant from the National Institutes of Health to accelerate development of its new DiscoveryDot(TM) High Throughput Screening technology for drug discovery. The NIH grant is part of the Screening Roadmap, designed to produce innovative chemical tools for use in biological research and drug development. Out of 8 recipients of grants pursuant to the original RFA, Reaction Biology is the only private corporation to be so awarded.
Clinical Study Confirms Safety and Efficacy of Novel Germicidal Device to Help Prevent Hospital-Acquired Infections
| From: UVSolutions LLC
BOSTON, MA – Feb. 22 (SEND2PRESS NEWSWIRE) — Catheter site infections are among the most common and serious hospital-acquired infections. UVSolutions announces that data from a recently completed clinical study confirms its patented catheter site disinfection system (also patented for wound care) is safe and efficacious on the most sensitive skin.
| From: JOE Product Promotions
HOUSTON, TX – Oct. 17 (SEND2PRESS NEWSWIRE) — Already widely distributed in Canada, Australia, and Europe, JOE Product Promotions has announced that a portable and disposable peeing device for women, called the P-mate, is set to make its debut in the United States.
One Last Chance for Pregnancy: A Review of 2,705 In Vitro Fertilization Cycles Initiated in Women Age 40 Years and Above
| From: Karande and Associates
HOFFMAN ESTATES, Ill. – August 31 (SEND2PRESS NEWSWIRE) — Karande and Associates today announces the recently published article by Sigal Klipstein, MD in Fertility and Sterility entitled: ‘One last chance for pregnancy: a review of 2,705 in vitro fertilization cycles initiated in women age 40 years and above.’ This investigation is the largest and most detailed ever published to look at fertility success rates within this population.
| From: The Sher Institutes for Reproductive Medicine (SIRM)
LOS ANGELES, Calif. – July 28 (SEND2PRESS NEWSWIRE) — A recent breakthrough in the field of In Vitro Fertilization (IVF), being offered in Southern California exclusively at the Sher Institute for Reproductive Medicine (SIRM-Los Angeles), may dramatically increase the odds of a woman getting pregnant through IVF, while at the same time reducing the likelihood of multiple births.
| From: Sher Institute for Reproductive Medicine
BEDMINSTER, NJ – July 22 (SEND2PRESS NEWSWIRE) — The Sher Institute for Reproductive Medicine (SIRM-New Jersey) in Bedminster has implemented a new genetic test that may dramatically increase the odds of a woman getting pregnant through In Vitro Fertilization (IVF), while at the same time reducing the likelihood of multiple births.
| From: Sleep Solvers
BOCA RATON, Fla. – May 13 (SEND2PRESS NEWSWIRE) — Sleep Solvers, a division of Sleep Diagnostic Centers LLC, announces the grand opening of their Boca Raton sleep laboratory. They offer sleep diagnostic testing and treatment programs for patients suspected of, or suffering from one or more of the over 70 types of sleep related problems. Unlike the conventional, hospital or clinical-based sleep laboratory, Sleep Solvers’ use of hotel-style diffuses the clinical appearance and feel of sleep diagnostic testing and treatment to create a comfortable and calming environment in order to alleviate the fear and anxiety of sleep testing and treatment.
Stratosphere and UV Solutions Partner to Create Product Disinfection Platform – Pacifier Market is Focus for First Products
| From: Stratosphere Partners LLC
BOSTON, Mass.- May 5 (SEND2PRESS NEWSWIRE) — Stratosphere Partners LLC, a Knowledge Venturing(tm) company that specializes in building new platform businesses and UV Solutions LLC, a pioneer of UV flash disinfection technologies today announce that they have formed a partnership to build a UV disinfection platform and brand based on UV Solutions’ patented technology.
| From: Special Abilities, Inc.
SALT LAKE CITY, UT — (SEND2PRESS NEWSWIRE) — Reports of a new study by Special Abilities, Inc. send an alarming message to parents of young infants and children. Pediatricians are not recognizing the symptoms of Autism Spectrum Disorder (ASD) at an early age denying children benefits of early intervention and therapy. Autism is a complex neurological disorder characterized by profound delays in communication and social interaction and affects over 1.7 million individuals in the U.S.